[1]
H. Singh, N. K. Natt, N. Garewal, and P. T., “Bedaquiline: a new weapon against MDR and XDR-TB”, Int J Basic Clin Pharmacol, vol. 2, no. 2, pp. 96–102, Jan. 2017.